MEDINET Co., Ltd. (2370.T)
Tokyo · JPY · Healthcare · Biotechnology
¥20 (-9.09%) as of
Key statistics
- Market cap
- 5.63B
- EPS (TTM)
- -311.95
- Dividend yield
- 0.00%
- 52-week range
- 20.00 – 39.00
- Beta
- 0.40
- Revenue (TTM)
- 998M
- Profit margin
- 0.00%
- Volume
- 787.50k
About MEDINET Co., Ltd.
MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan. It operates through two segments: Cell Processing Business and Regenerative Medicine Products Business.The company's solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy.It also manufactures regenerative medical/investigational and specified cell products. In addition, the company offers value chain solutions, such as personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management system, quality control and assurance, and technology transfer and process development solutions. The company serves medical institutions, research institutions, and biopharmaceutical companies. MEDINET Co., Ltd. was incorporated in 1995 and is headquartered in Tokyo, Japan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Tokyo, Japan
- Employees
- 92
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.